Mrs. Kawanda C Frazier Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 175 Gwinnett Drive, Lawreceville, GA 30045 Phone: 770-339-5377 |
News Archive
Incyte Corporation (Nasdaq: INCY) today announced that a pivotal Phase III trial of ruxolitinib compared to best available therapy in patients with polycythemia vera who are resistant to or intolerant of hydroxyurea has met its primary endpoint of achieving phlebotomy independence and reducing spleen size by 35 percent or more.
Researchers believe that the side effects of chemotherapy treatment for breast cancer are probably higher than thought.
California officials worry that highly publicized problems of the federal website will scare customers away from the state marketplace, which is open for business. Meanwhile, news outlets look at issues in New York, Connecticut, Texas and Minnesota.
Key data from Boehringer Ingelheim's hepatitis C virus (HCV) clinical trial programme, HCVerso, focusing on interferon-free treatment, has been selected for inclusion in the official European Association for the Study of the Liver (EASL) press office activities.
› Verified 6 days ago